09/12/2025
Prostate cancer is the second most common cancer in men, according to the World Cancer Research Fund. 💙📊
Radiotherapy is one of the primary treatment approaches for prostate cancer. In recent years, more and more sites are performing moderate or even ultra-hypofractionated treatments with the total dose applied in fewer sessions.
One prime example is Vychodoslovensky onkologicky ustav (VOU) in Kosice, Slovakia, where our ExacTrac Dynamic® Implanted Marker Workflow enables the team to optimize their fiducial-based IGRT practice. This allows them to significantly increase their patient load while also increasing accuracy.
🎥 Watch Pavol Dubinský, MD, discuss how their practice at VOU has evolved since installing ExacTrac Dynamic five years ago and how patients are reaping the benefits.
https://bit.ly/44dT21t
*The statements made by the clinician represent their professional opinion and experience. These statements may not be supported by scientific evidence or peer-reviewed research. For verified information about the device, please refer to the manufacturer's official documentation.